Vanguard Group Inc Edwards Lifesciences Corp Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Vanguard Group Inc holds 69,997,629 shares of EW stock, worth $5.38 Billion. This represents 0.09% of its overall portfolio holdings.

Number of Shares
69,997,629
Previous 69,198,828 1.15%
Holding current value
$5.38 Billion
Previous $5.02 Billion 9.15%
% of portfolio
0.09%
Previous 0.09%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$67.07 - $78.22 $53.6 Million - $62.5 Million
798,801 Added 1.15%
69,997,629 $5.47 Billion
Q1 2025

May 09, 2025
BUY
$67.95 - $76.19 $4.54 Million - $5.09 Million
66,792 Added 0.1%
69,198,828 $5.02 Billion
Q4 2024

Feb 11, 2025
BUY
$64.54 - $75.92 $422 Million - $496 Million
6,537,494 Added 10.44%
69,132,036 $5.12 Billion
Q3 2024

Nov 13, 2024
BUY
$59.7 - $93.78 $538 Million - $846 Million
9,018,528 Added 16.83%
62,594,542 $4.13 Billion
Q2 2024

Aug 13, 2024
BUY
$84.3 - $94.31 $51.6 Million - $57.7 Million
611,620 Added 1.15%
53,576,014 $4.95 Billion
Q1 2024

May 10, 2024
BUY
$72.54 - $95.56 $43.6 Million - $57.4 Million
600,994 Added 1.15%
52,964,394 $5.06 Billion
Q4 2023

Mar 11, 2024
BUY
$61.71 - $77.76 $30,052 - $37,869
487 Added 0.0%
52,363,400 $3.99 Billion
Q4 2023

Feb 14, 2024
BUY
$61.71 - $77.76 $45 Million - $56.7 Million
729,497 Added 1.41%
52,362,913 $3.99 Billion
Q3 2023

Nov 14, 2023
BUY
$69.28 - $93.38 $22.6 Million - $30.4 Million
325,808 Added 0.64%
51,633,416 $3.58 Billion
Q2 2023

Aug 14, 2023
SELL
$81.41 - $94.33 $36.1 Million - $41.8 Million
-443,619 Reduced 0.86%
51,307,608 $4.84 Billion
Q1 2023

Jul 14, 2023
BUY
$74.26 - $84.51 $29,109 - $33,127
392 Added 0.0%
51,751,227 $4.28 Billion
Q1 2023

May 15, 2023
BUY
$74.26 - $84.51 $14.2 Million - $16.2 Million
191,444 Added 0.37%
51,750,835 $4.28 Billion
Q4 2022

Feb 10, 2023
BUY
$68.3 - $87.44 $44.3 Million - $56.7 Million
648,287 Added 1.27%
51,559,391 $3.85 Billion
Q3 2022

Nov 14, 2022
BUY
$82.37 - $107.29 $49.8 Million - $64.8 Million
604,269 Added 1.2%
50,911,104 $4.21 Billion
Q2 2022

Aug 12, 2022
BUY
$86.5 - $128.27 $50.3 Million - $74.6 Million
581,969 Added 1.17%
50,306,835 $4.78 Billion
Q1 2022

May 13, 2022
BUY
$101.96 - $128.34 $66.1 Million - $83.2 Million
648,217 Added 1.32%
49,724,866 $5.85 Billion
Q4 2021

Feb 14, 2022
BUY
$106.37 - $130.68 $28.7 Million - $35.3 Million
269,987 Added 0.55%
49,076,649 $6.36 Billion
Q3 2021

Nov 12, 2021
BUY
$102.91 - $122.75 $51.2 Million - $61 Million
497,212 Added 1.03%
48,806,662 $5.53 Billion
Q2 2021

Aug 13, 2021
BUY
$83.84 - $104.76 $4.05 Billion - $5.06 Billion
48,309,450 New
48,309,450 $5 Billion

Others Institutions Holding EW

# of Institutions
1,441
Shares Held
485M
Call Options Held
2.76M
Put Options Held
1.54M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $47.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email